These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35395708)

  • 41. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
    Lon JR; Bai Y; Zhong B; Cai F; Du H
    Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
    Kitsou K; Kotanidou A; Paraskevis D; Karamitros T; Katzourakis A; Tedder R; Hurst T; Sapounas S; Kotsinas A; Gorgoulis V; Spoulou V; Tsiodras S; Lagiou P; Magiorkinis G
    Microbiol Spectr; 2021 Oct; 9(2):e0126021. PubMed ID: 34612698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mimicry may explain multi-organ damage in COVID-19.
    Angileri F; Legare S; Marino Gammazza A; Conway de Macario E; Jl Macario A; Cappello F
    Autoimmun Rev; 2020 Aug; 19(8):102591. PubMed ID: 32535095
    [No Abstract]   [Full Text] [Related]  

  • 47. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
    Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
    Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates.
    Normatov MG; Karev VE; Kolobov AV; Mayevskaya VA; Ryabkova VA; Utekhin VJ; Churilov LP
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The landscape of antibody binding in SARS-CoV-2 infection.
    Heffron AS; McIlwain SJ; Amjadi MF; Baker DA; Khullar S; Armbrust T; Halfmann PJ; Kawaoka Y; Sethi AK; Palmenberg AC; Shelef MA; O'Connor DH; Ong IM
    PLoS Biol; 2021 Jun; 19(6):e3001265. PubMed ID: 34143766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?
    Carnevale S; Giovanetti M; Benvenuto D; Ciccozzi M; Broccolo F
    Semin Thromb Hemost; 2023 Feb; 49(1):103-104. PubMed ID: 35021248
    [No Abstract]   [Full Text] [Related]  

  • 55. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?
    Cappello F
    Cell Stress Chaperones; 2020 May; 25(3):381-382. PubMed ID: 32314313
    [No Abstract]   [Full Text] [Related]  

  • 56. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
    Ahmad F; Kamal MA; Tekwani BL
    Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
    Xia J; Zeng Y; Tan Z; Chen T; Hu W; Shuai S; Cao D; Zeng X
    AIDS Rev; 2021 Jun; 23(3):153-163. PubMed ID: 34082440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.